M. Wayne Saville

2.2k total citations
34 papers, 1.7k citations indexed

About

M. Wayne Saville is a scholar working on Oncology, Pathology and Forensic Medicine and Virology. According to data from OpenAlex, M. Wayne Saville has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 9 papers in Virology. Recurrent topics in M. Wayne Saville's work include Lymphoma Diagnosis and Treatment (12 papers), HIV Research and Treatment (9 papers) and Viral-associated cancers and disorders (8 papers). M. Wayne Saville is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), HIV Research and Treatment (9 papers) and Viral-associated cancers and disorders (8 papers). M. Wayne Saville collaborates with scholars based in United States, Germany and Canada. M. Wayne Saville's co-authors include Robert Yarchoan, S Broder, James M. Pluda, Andrea Foli, Seth M. Steinberg, Jill Lietzau, Hideo Asada, David J. Altman, Vera Klaus-Kovtun and Andrew Blauvelt and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

M. Wayne Saville

34 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Wayne Saville United States 20 652 607 494 388 371 34 1.7k
Yuri Fedoriw United States 23 640 1.0× 527 0.9× 331 0.7× 208 0.5× 103 0.3× 110 1.9k
Samuel J. Pirruccello United States 26 495 0.8× 218 0.4× 873 1.8× 153 0.4× 314 0.8× 79 2.4k
Martina Vockerodt Germany 21 1.0k 1.6× 751 1.2× 702 1.4× 159 0.4× 79 0.2× 38 2.2k
Paul E. Hurtubise United States 22 335 0.5× 227 0.4× 407 0.8× 225 0.6× 61 0.2× 60 1.4k
Yoshihiro Yakushijin Japan 23 766 1.2× 421 0.7× 493 1.0× 268 0.7× 52 0.1× 87 1.6k
Elaine J. Schattner United States 19 665 1.0× 565 0.9× 1.1k 2.1× 539 1.4× 39 0.1× 31 2.0k
Mariagrazia Michieli Italy 24 1.2k 1.8× 553 0.9× 162 0.3× 376 1.0× 56 0.2× 107 1.9k
Yaoyu E. Wang United States 21 368 0.6× 148 0.2× 331 0.7× 74 0.2× 351 0.9× 35 1.6k
Nabih Azar France 19 245 0.4× 344 0.6× 159 0.3× 357 0.9× 38 0.1× 41 1.3k
Camille N. Abboud United States 26 815 1.3× 150 0.2× 687 1.4× 152 0.4× 48 0.1× 71 2.7k

Countries citing papers authored by M. Wayne Saville

Since Specialization
Citations

This map shows the geographic impact of M. Wayne Saville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wayne Saville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wayne Saville more than expected).

Fields of papers citing papers by M. Wayne Saville

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Wayne Saville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wayne Saville. The network helps show where M. Wayne Saville may publish in the future.

Co-authorship network of co-authors of M. Wayne Saville

This figure shows the co-authorship network connecting the top 25 collaborators of M. Wayne Saville. A scholar is included among the top collaborators of M. Wayne Saville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Wayne Saville. M. Wayne Saville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsimberidou, Apostolia M., Axel Grothey, Darren Sigal, et al.. (2024). Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 94(6). 787–798. 1 indexed citations
2.
Srinivasan, Sangeetha, et al.. (2021). Abstract 1347: The CAPAC Platform maximizes therapeutic benefit and reduces systemic cytotoxic exposure in small and large animals. Cancer Research. 81(13_Supplement). 1347–1347. 1 indexed citations
3.
Subbiah, Vivek, Vivek A. Bhadri, Nam Q. Bui, et al.. (2021). 547P Early pharmacokinetic data from a phase I study of SQ3370 in patients with advanced solid tumors provides proof-of-concept for the click chemistry-based CAPAC platform. Annals of Oncology. 32. S609–S609. 3 indexed citations
4.
Patel, Krish, Jean‐Marie Michot, Asher Chanan‐Khan, et al.. (2019). Preliminary Safety and Anti-Tumor Activity of XmAb13676, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. Blood. 134(Supplement_1). 4079–4079. 24 indexed citations
5.
Hagiwara, May, Thomas E. Delea, M. Wayne Saville, & Karen Chung. (2012). Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases. Prostate Cancer and Prostatic Diseases. 16(1). 23–27. 52 indexed citations
6.
Robak, Tadeusz, Anna Dmoszyńska, Philippe Solal‐Céligny, et al.. (2010). Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 28(10). 1756–1765. 358 indexed citations
7.
Emmanouilides, Christos, Thomas E. Witzig, Gregory A. Wiseman, et al.. (2007). Safety and Efficacy of Yttrium-90 Ibritumomab Tiuxetan in Older Patients With Non-Hodgkin's Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 22(5). 684–691. 29 indexed citations
8.
Esmaeli, Bita, Barbara Pro, M. Wayne Saville, & Peter McLaughlin. (2005). Rituximab and Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy May Be Feasible Options in Patients with Low-Grade Lymphoma of the Orbit.. Blood. 106(11). 4792–4792. 1 indexed citations
9.
Macklis, Roger M., A. Molina, Brad Pohlman, et al.. (2004). Long-term responses in patients with relapsed or refractory follicular lymphoma treated with yttrium 90 ibritumomab tiuxetan (Zevalin). International Journal of Radiation Oncology*Biology*Physics. 60(1). S542–S543. 4 indexed citations
10.
Miles, Steven A., Bruce J. Dezube, Jeannette Y. Lee, et al.. (2002). Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma. AIDS. 16(3). 421–429. 42 indexed citations
11.
Tulpule, Anil, Jerome E. Groopman, M. Wayne Saville, et al.. (2002). Multicenter trial of low‐dose paclitaxel in patients with advanced AIDS‐related Kaposi sarcoma. Cancer. 95(1). 147–154. 110 indexed citations
12.
Welles, Lauri, M. Wayne Saville, Jill Lietzau, et al.. (1998). Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.. Journal of Clinical Oncology. 16(3). 1112–1121. 127 indexed citations
13.
Blauvelt, Andrew, Hideo Asada, M. Wayne Saville, et al.. (1997). Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.. Journal of Clinical Investigation. 100(8). 2043–2053. 162 indexed citations
14.
Foli, Andrea, M. Wayne Saville, Lester T. May, Deborah Webb, & Robert Yarchoan. (1997). Effects of Human Immunodeficiency Virus and Colony-Stimulating Factors on the Production of Interleukin 6 and Tumor Necrosis Factor α by Monocyte/Macrophages. AIDS Research and Human Retroviruses. 13(10). 829–839. 11 indexed citations
15.
Štefanová, Irena, M. Wayne Saville, Christian Peters, et al.. (1996). HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.. Journal of Clinical Investigation. 98(6). 1290–1297. 79 indexed citations
16.
Piscitelli, Stephen C., et al.. (1996). Immune-Based Therapies for Treatment of HIV Infection. Annals of Pharmacotherapy. 30(1). 62–76. 6 indexed citations
17.
Pluda, James M., Andrea Foli, M. Wayne Saville, et al.. (1995). Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.. Journal of Clinical Oncology. 13(8). 1966–1974. 40 indexed citations
18.
Saville, M. Wayne, Jill Lietzau, James M. Pluda, et al.. (1995). Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. The Lancet. 346(8966). 26–28. 146 indexed citations
19.
20.
Yarchoan, Robert, Jill Lietzau, Otis W. Brawley, et al.. (1994). A Randomized Pilot Study of Alternating or Simultaneous Zidovudine and Didanosine Therapy in Patients with Symptomatic Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 169(1). 9–17. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuri Fedoriw Breakdown of academic impact, for papers by Samuel J. Pirruccello Breakdown of academic impact, for papers by Martina Vockerodt Breakdown of academic impact, for papers by Paul E. Hurtubise Breakdown of academic impact, for papers by Yoshihiro Yakushijin Breakdown of academic impact, for papers by Elaine J. Schattner Breakdown of academic impact, for papers by Mariagrazia Michieli Breakdown of academic impact, for papers by Yaoyu E. Wang Breakdown of academic impact, for papers by Nabih Azar Breakdown of academic impact, for papers by Camille N. Abboud
Rankless by CCL
2026